{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "31344116",
  "DateCompleted": {
    "Year": "2020",
    "Month": "03",
    "Day": "31"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "03",
    "Day": "31"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2019",
        "Month": "07",
        "Day": "25"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e0220371",
      "10.1371/journal.pone.0220371"
    ],
    "Journal": {
      "ISSN": "1932-6203",
      "JournalIssue": {
        "Volume": "14",
        "Issue": "7",
        "PubDate": {
          "Year": "2019"
        }
      },
      "Title": "PloS one",
      "ISOAbbreviation": "PLoS One"
    },
    "ArticleTitle": "Quantifying the incidence of severe-febrile-illness hospital admissions in sub-Saharan Africa.",
    "Pagination": {
      "StartPage": "e0220371",
      "MedlinePgn": "e0220371"
    },
    "Abstract": {
      "AbstractText": [
        "Severe-febrile-illness (SFI) is a common cause of morbidity and mortality across sub-Saharan Africa (SSA). The burden of SFI in SSA is currently unknown and its estimation is fraught with challenges. This is due to a lack of diagnostic capacity for SFI in SSA, and thus a dearth of baseline data on the underlying etiology of SFI cases and scant SFI-specific causative-agent prevalence data. To highlight the public health significance of SFI in SSA, we developed a Bayesian model to quantify the incidence of SFI hospital admissions in SSA. Our estimates indicate a mean population-weighted SFI-inpatient-admission incidence rate of 18.4 (6.8-31.1, 68% CrI) per 1000 people for the year 2014, across all ages within areas of SSA with stable Plasmodium falciparum transmission. We further estimated a total of 16,200,337 (5,993,249-27,321,779, 68% CrI) SFI hospital admissions. This analysis reveals the significant burden of SFI in hospitals in SSA, but also highlights the paucity of pathogen-specific prevalence and incidence data for SFI in SSA. Future improvements in pathogen-specific diagnostics for causative agents of SFI will increase the abundance of SFI-specific prevalence and incidence data, aid future estimations of SFI burden, and enable clinicians to identify SFI-specific pathogens, administer appropriate treatment and management, and facilitate appropriate antibiotic use."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-3919-7942"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "M\u00e9decins Sans Fronti\u00e8res - Febrile Illness Diagnostic Programme, New York, United States of America."
          }
        ],
        "LastName": "Roddy",
        "ForeName": "Paul",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Oxford, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Oxford, United Kingdom."
          }
        ],
        "LastName": "Dalrymple",
        "ForeName": "Ursula",
        "Initials": "U"
      },
      {
        "Identifier": [
          "0000-0003-0398-4431"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "M\u00e9decins Sans Fronti\u00e8res - Febrile Illness Diagnostic Programme, New York, United States of America."
          }
        ],
        "LastName": "Jensen",
        "ForeName": "Tomas O",
        "Initials": "TO"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland."
          },
          {
            "Identifier": [],
            "Affiliation": "University of Oxford - Nuffield School of Medicine, Oxford, United Kingdom."
          }
        ],
        "LastName": "Dittrich",
        "ForeName": "Sabine",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "M\u00e9decins Sans Fronti\u00e8res - Manson Unit (MSF UK), London, United Kingdom."
          }
        ],
        "LastName": "Rao",
        "ForeName": "V Bhargavi",
        "Initials": "VB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Oxford, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Oxford, United Kingdom."
          },
          {
            "Identifier": [],
            "Affiliation": "Menzies School of Health Research and Charles Darwin University, Darwin, Australia."
          }
        ],
        "LastName": "Pfeffer",
        "ForeName": "Daniel A",
        "Initials": "DA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "University of Oxford, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Oxford, United Kingdom."
          }
        ],
        "LastName": "Twohig",
        "ForeName": "Katherine A",
        "Initials": "KA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "M\u00e9decins Sans Fronti\u00e8res - Febrile Illness Diagnostic Programme, New York, United States of America."
          },
          {
            "Identifier": [],
            "Affiliation": "M\u00e9decins Sans Fronti\u00e8res - Access Campaign, Geneva, Switzerland."
          }
        ],
        "LastName": "Roberts",
        "ForeName": "Teri",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "M\u00e9decins Sans Fronti\u00e8res - Febrile Illness Diagnostic Programme, New York, United States of America."
          }
        ],
        "LastName": "Bernal",
        "ForeName": "Oscar",
        "Initials": "O"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "M\u00e9decins Sans Fronti\u00e8res - Febrile Illness Diagnostic Programme, New York, United States of America."
          }
        ],
        "LastName": "Guillen",
        "ForeName": "Ethan",
        "Initials": "E"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "PLoS One",
    "NlmUniqueID": "101285081",
    "ISSNLinking": "1932-6203"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "Africa South of the Sahara"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Child, Preschool"
    },
    {
      "QualifierName": [
        "complications",
        "diagnosis",
        "epidemiology"
      ],
      "DescriptorName": "Community-Acquired Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "diagnosis",
        "epidemiology",
        "etiology",
        "pathology"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Hospitalization"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Incidence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Infant, Newborn"
    },
    {
      "QualifierName": [
        "complications",
        "diagnosis",
        "epidemiology"
      ],
      "DescriptorName": "Malaria"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Medical Overuse"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "statistics & numerical data"
      ],
      "DescriptorName": "Patient Admission"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prevalence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Severity of Illness Index"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ],
  "CoiStatement": "The authors have declared that no competing interests exist."
}